Case Studies
Featured
Merger debuts McDermott Will & Schulte, new legal powerhouse
McDermott verstärkt Transaktionspraxis mit Johannes Eckhardt als Partner
McDermott berät Cognism beim Verkauf von NETSTAG an die Positive Group
McDermott berät NORD Holding und 1Q Health Group beim Erwerb der Beauty Production GmbH
June 4, 2026
McDermott Will & Schulte boosts government contracts bench with experienced Department of War litigator
June 2, 2026
McDermott Will & Schulte represents Amulet Capital Partners in merger of Alliance Clinical Network and Atlas Clinical Research
McDermott advises the Arcaplanet Group on its acquisition of Animal Store
29 Mai 2026
McDermott berät LLCP Portfoliogesellschaft cleversoft bei Übernahme der FAIT Internet Software
May 28, 2026
McDermott Will & Schulte represents Ampersand Capital Partners in close of oversubscribed fund at $1.5 billion hard cap
May 27, 2026
Henry Smokler discusses the growing demand for MLB franchises in The Athletic
McDermott Will & Schulte represents Texture in its $12.5M Series A financing
27. Mai 2026
McDermott berät Almirall bei Kooperation mit Huaota
May 25, 2026
Europe’s dealmakers warn of EU merger policy confusion
May 26, 2026
McDermott Will & Schulte strengthens employment litigation offering with MiRi Song arrival in Los Angeles
25. Mai 2026
Die extraterritoriale Durchsetzung von Patenten – vom Kuriosum zum Königsweg
May 21, 2026
McDermott Will & Schulte advises Ranova (JZ International) in the acquisition of Fidermoney
McDermott Will & Schulte advises Voodoo’s co-founder on his acquisition of a majority stake in DC Company
May 20, 2026
Doug Carsten and Bill Gaede named among Top Intellectual Property Lawyers by Daily Journal
20. Mai 2026
McDermott berät OLB bei der Finanzierung der Übernahme der Blasius Schuster Group durch AUCTUS
Mai 20, 2026
„Leverest Relationship Tracker“: McDermott verteidigt Top-Position als Berater bei Akquisitionsfinanzierungen in der DACH-Region
May 19, 2026
McDermott represents Boyne Capital in close of oversubscribed Fund III at over $400 million
McDermott Will & Schulte advise Pet Being on acquisition of a majority stake in General & Pharma